Skip to main content

Table 1 Clinical characteristics of the study population

From: Association between predicted fat mass, predicted lean mass, predicted percent fat and type 2 diabetes mellitus in Japanese adults: a retrospective study

  

Men

Women

 

Variables

Non - T2DM (n = 8133)

T2DM(n = 286)

p value

Non - T2DM (n = 6947)

T2DM(n = 87)

p value

Age, (years)

44.0 ± 9.0

47.0 ± 8.5

< 0.001

43.2 ± 8.7

47.6 ± 8.5

< 0.001

Habit of exercise, n(%)

  

0.019

  

0.611

 No

6575 (80.8)

247 (86.4)

 

5850 (84.2)

75 (86.2)

 

 Yes

1558 ( 19.2)

39 ( 13.6)

 

1097 ( 15.8)

12 ( 13.8)

 

Alcohol consumption, n(%)

  

0.018

  

0.394

 None

5167 (63.5)

184 (64.3)

 

6369 (91.7)

82 (94.3)

 

 Light

1327 ( 16.3)

38 ( 13.3)

 

387 (5.6)

2 (2.3)

 

 Moderate

1129 ( 13.9)

34 ( 11.9)

 

191 (2.7)

3 (3.4)

 

 Heavy

510 (6.3)

30 ( 10.5)

 

0

0

 

Smoking status, n(%)

  

< 0.001

  

0.02

 Never

2813 (34.6)

75 (26.2)

 

6069 (87.4)

70 (80.5)

 

 Past

2436 (30)

72 (25.2)

 

436 (6.3)

5 (5.7)

 

 Current

2884 (35.5)

139 (48.6)

 

442 (6.4)

12 ( 13.8)

 

ALT, (IU/L)

20.0 (15.0, 27.0)

28.0 (20.0, 42.8)

< 0.001

14.0 (11.0, 17.0)

19.0 (14.0, 23.0)

< 0.001

AST, (IU/L)

18.0 (15.0, 23.0)

20.5 (17.0, 26.8)

< 0.001

16.0 (13.0, 19.0)

18.0 (15.0, 22.0)

< 0.001

GGT, (IU/L)

19.0 (15.0, 28.0)

26.0 (19.0, 39.8)

< 0.001

12.0 (10.0, 15.0)

15.0 (12.0, 22.5)

< 0.001

HDL-c, (mg/dL)

50.7 ± 13.4

43.5 ± 11.5

< 0.001

63.9 ± 14.8

53.9 ± 13.3

< 0.001

TC, (mg/dL)

198.0 (176.0, 220.0)

210.0 (185.0, 229.0)

< 0.001

194.0 (172.0, 218.0)

212.0 (188.5, 241.5)

< 0.001

TG, (mg/dL)

81.0 (56.0, 121.0)

125.5 (80.5, 189.0)

< 0.001

50.0 (36.0, 71.0)

85.0 (64.5, 115.5)

< 0.001

HbA1c, (%)

5. 1 ± 0.3

5.5 ± 0.4

< 0.001

5.2 ± 0.3

5.6 ± 0.4

< 0.001

FPG, (mg/dL)

95.4 ± 6.6

101.9 ± 5.9

< 0.001

89.7 ± 7.0

98.6 ± 7.4

< 0.001

SBP, (mmHg)

118.6 ± 14. 1

123.5 ± 15.5

< 0.001

109.3 ± 14.3

117.0 ± 15.0

< 0.001

DBP, (mmHg)

74.7 ± 9.9

78.5 ± 10.2

< 0.001

67.6 ± 9.8

72.9 ± 9.3

< 0.001

BodyWeight, (kg)

67. 1 ± 9.8

73.0 ± 12.3

< 0.001

52.6 ± 7.8

59.5 ± 11. 1

< 0.001

Height, (cm)

170.8 ± 6.0

170.0 ± 6.0

0.016

158.3 ± 5.4

155.9 ± 6.5

< 0.001

BMI, (kg/m2)

23.0 ± 2.9

25.2 ± 3.6

< 0.001

21.0 ± 2.9

24.5 ± 4.4

< 0.001

WC, (cm)

80.3 ± 7.8

86.5 ± 9.2

< 0.001

71.6 ± 8.0

80.4 ± 11.8

< 0.001

WHtR

47.0 ± 4.6

50.9 ± 5.2

< 0.001

45.2 ± 5. 1

51.6 ± 7.7

< 0.001

FM

24.4 ± 5.8

28.6 ± 7.2

< 0.001

9.0 ± 4.5

14. 1 ± 6.8

< 0.001

LM

41.3 ± 4.2

43.0 ± 5.2

< 0.001

42. 1 ± 4. 1

43.9 ± 5.3

< 0.001

PF

35.7 ± 3. 1

38.4 ± 3.5

< 0.001

20.2 ± 3.3

24. 1 ± 4.9

< 0.001

  1. Data were mean ± SD or median (IQR) for continuous variables or numbers (proportions) for categorical variables
  2. ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma glutamyl transferase, HDL-c high‐density lipoprotein cholesterol, TC total cholesterol, TG triglyceride, HbA1c hemoglobin A1c, FPG fasting plasma glucose, SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, WC waist circumference, WHtR waist‐‐height ratio, T2DM type 2 diabetes mellitus, FM predicted fat mass, LM predicted lean mass, PF predicted per cent fat, Q1, Q2, Q3 are tertiles of the predicted FM, LM, PF